Newsroom

EL PASO, Texas--(BUSINESS WIRE)--Helen of Troy Limited (NASDAQ: HELE), designer, developer, and worldwide marketer of branded consumer home, outdoor, beauty, and wellness products, today announced that the Company will release its third quarter fiscal year 2026 results before the stock market opens on Thursday, January 8, 2026. The Company will conduct a conference call to discuss its third quarter fiscal year 2026 results on the same day, Thursday, January 8, 2026, at 9:00 a.m. Eastern Time. T...

MIDLAND, Texas--(BUSINESS WIRE)--Permian Resources Corporation (NYSE: PR) (“Permian Resources,” “we,” “us,” “our” or the “Company”) today announced a corporate reorganization pursuant to which Permian Resources’ management team members and other long-term holders are exchanging their Class C shares for Class A shares. This transaction better aligns management ownership with public investors, enhances the ability of management team members to maintain peer-leading ownership and advances Permian...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conference: J.P. Morgan Healthcare Conference on Monday, January 12, 2026 beginning at 11:15 a.m. Pacific Time The live webcast can be accessed at investors.gilead.com and the replay will be available for at least 30 days following the presentation. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired F5, Inc. (NASDAQ: FFIV) securities between October 28, 2024 and October 27, 10, 2025. F5 is a global multicloud application security and delivery company that enables customers to deploy, secure, and operate applications on-premises or via public cloud. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at...

PASADENA, Calif.--(BUSINESS WIRE)--Tetra Tech, Inc. (NASDAQ: TTEK), a leading provider of high-end consulting and engineering services in water, environment, and sustainable infrastructure, announced today that M. Susan Hardwick, recently retired Chief Executive Officer of American Water, has been appointed to the Company’s Board of Directors, effective December 29, 2025. Ms. Hardwick will serve on the Audit Committee and the Nominating and Corporate Governance Committee. Ms. Hardwick is a high...

BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company, today announced its financial results for the full year ended October 31, 2025, and provided a business update. “We are closing 2025 in a position of strength: enrollment in LEGEND's pivotal cohort is complete and the recent data update from the LEGEND pivotal cohort supports an emerging, competitive profile for the use of detalimogene as the...

PASADENA, Calif.--(BUSINESS WIRE)--Tetra Tech, Inc. (NASDAQ: TTEK), a leading provider of high-end consulting and engineering services in water, environment, and sustainable infrastructure, announced today that Jeffrey R. (Jeff) Feeler, former Chairman, Chief Executive Officer, and President of US Ecology, has been appointed to the Company’s Board of Directors, effective December 29, 2025. Mr. Feeler will serve on the Audit Committee and the Compensation Committee. Mr. Feeler brings more than 3...

DALLAS--(BUSINESS WIRE)--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on developing FB102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications, today announced the issuance of an equity inducement award as required by the Nasdaq Stock Market Rules. In accordance with NASDAQ Listing Rule 5635(c)(4), the Compensation Committee of Forte’s B...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 5:15 p.m. ET/2:15 p.m. PT. A live webcast of management’s remarks will be available through the Vertex website, www.vrtx.com, in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on...

NEW YORK--(BUSINESS WIRE)--VanEck restates year-end distribution for Russia small-cap ETF....